⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1669826 | 0.81 | — | — | |
| SCHEMBL15850361 | 0.67 | — | — | |
| SCHEMBL1828683 | 0.67 | — | — | |
| Hydrogen Sulfide SCHEMBL27615479 | 0.65 | — | — | |
| SCHEMBL11225973 | 0.65 | — | — | |
| SCHEMBL28987305 | 0.63 | — | — | |
| SCHEMBL2059055 | 0.63 | — | — | |
| SCHEMBL15358714 | 0.63 | — | — | |
| SCHEMBL15080984 | 0.63 | — | — | |
| SCHEMBL1628847 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9913912-B2 | Carrier-linked prostanoid prodrugs | ASCENDIS PHARMA A/S (DE) | 2018-03-13 | — | — | US | disclosed |
| EP-2525830-B1 | DIPEPTIDE-BASED PRODRUG LINKERS FOR ALIPHATIC AMINE-CONTAINING DRUGS | ASCENDIS PHARMA AS (DK) | 2016-05-11 | — | — | EP | disclosed |
| EP-2988783-A1 | HYDROGEL-LINKED PRODRUGS RELEASING MODIFIED DRUGS | Ascendis Pharma A/S (DK) | 2016-03-02 | — | — | EP | disclosed |
| US-20150306239-A1 | Carrier-Linked Prostanoid Prodrugs | ASCENDIS PHARMA A/S (DK) | 2015-10-29 | — | — | US | disclosed |
| WO-2014173759-A1 | HYDROGEL-LINKED PRODRUGS RELEASING MODIFIED DRUGS | ASCENDIS PHARMA A/S (DK) | 2014-10-30 | — | — | WO | disclosed |
| EP-2741738-A1 | SUSTAINED RELEASE COMPOSITION OF PROSTACYCLIN | Ascendis Pharma A/S (DK) | 2014-06-18 | — | — | EP | disclosed |
| EP-2741781-A1 | CARRIER-LINKED TREPROSTINIL PRODRUGS | Ascendis Pharma A/S (DK) | 2014-06-18 | — | — | EP | disclosed |
| EP-2741744-A1 | CARRIER-LINKED PRODRUGS HAVING REVERSIBLE CARBOXYLIC ESTER LINKAGES | Ascendis Pharma A/S (DK) | 2014-06-18 | — | — | EP | disclosed |
| WO-2013024053-A1 | CARRIER-LINKED PRODRUGS HAVING REVERSIBLE CARBOXYLIC ESTER LINKAGES | ASCENDIS PHARMA A/S (DK) | 2013-02-21 | — | — | WO | disclosed |
| WO-2013024052-A1 | CARRIER-LINKED TREPROSTINIL PRODRUGS | ASCENDIS PHARMA A/S (DK) | 2013-02-21 | — | — | WO | disclosed |
| WO-2013024051-A1 | SUSTAINED RELEASE COMPOSITION OF PROSTACYCLIN | ASCENDIS PHARMA A/S (DK) | 2013-02-21 | — | — | WO | disclosed |
| WO-2011089216-A1 | DIPEPTIDE-BASED PRODRUG LINKERS FOR ALIPHATIC AMINE-CONTAINING DRUGS | ASCENDIS PHARMA AS (DK) | 2011-07-28 | — | — | WO | disclosed |
| WO-2011089214-A1 | CARRIER-LINKED CARBAMATE PRODRUG LINKERS | ASCENDIS PHARMA AS (DK) | 2011-07-28 | — | — | WO | disclosed |
| WO-2011089215-A1 | DIPEPTIDE-BASED PRODRUG LINKERS FOR AROMATIC AMINE-CONTAINING DRUGS | ASCENDIS PHARMA AS (DK) | 2011-07-28 | — | — | WO | disclosed |